Scientists scan brains on 'Magic Mushroom' compound
NCT ID NCT07050368
Summary
This early-stage study tested a low-dose form of psilocybin, the compound found in 'magic mushrooms,' in 20 healthy volunteers. Researchers used brain scans (fMRI) to see how the drug affects brain activity and connections. The main goals were to check the drug's safety, how the body processes it, and gather initial data for future research on conditions like OCD and addiction.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hammersmith Medicines Research (HMR)
London, NW10 7EW, United Kingdom
Conditions
Explore the condition pages connected to this study.